FDA recall D-0376-2021

Product

Methylprednisolone Acetate Injectable Suspension USP, 40 mg/mL, 10 mL Multiple Dose Vial, Rx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454 NDC 0703-0045-01

Reason for recall

Lack of Assurance of Sterility

Distribution

Product was distributed nationwide.

Key facts

Status

Terminated

Initiation date

2021-04-26

Report date

2021-05-26

Termination date

2024-06-04

Voluntary/Mandated

Voluntary: Firm initiated

Location

Parsippany, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0376-2021